These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25308265)

  • 1. Homogeneous, bioluminescent proteasome assays.
    O'Brien MA; Moravec RA; Riss TL; Bulleit RF
    Methods Mol Biol; 2015; 1219():95-114. PubMed ID: 25308265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homogeneous, bioluminescent proteasome assays.
    O'Brien MA; Moravec RA; Riss TL; Bulleit RF
    Methods Mol Biol; 2008; 414():163-81. PubMed ID: 18175819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based bioluminescent assays for all three proteasome activities in a homogeneous format.
    Moravec RA; O'Brien MA; Daily WJ; Scurria MA; Bernad L; Riss TL
    Anal Biochem; 2009 Apr; 387(2):294-302. PubMed ID: 19454251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogeneous, bioluminescent protease assays: caspase-3 as a model.
    O'Brien MA; Daily WJ; Hesselberth PE; Moravec RA; Scurria MA; Klaubert DH; Bulleit RF; Wood KV
    J Biomol Screen; 2005 Mar; 10(2):137-48. PubMed ID: 15799957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates.
    Kisselev AF; Goldberg AL
    Methods Enzymol; 2005; 398():364-78. PubMed ID: 16275343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capture proteasome assay: A method to measure proteasome activity in vitro.
    Vigneron N; Abi Habib J; Van den Eynde BJ
    Anal Biochem; 2015 Aug; 482():7-15. PubMed ID: 25912419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apigenin, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells.
    Wu YX; Fang X
    Planta Med; 2010 Feb; 76(2):128-32. PubMed ID: 19653143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity.
    Dettmer S; Theile D; Seckinger A; Burhenne J; Weiss J
    Anal Biochem; 2015 Feb; 471():23-5. PubMed ID: 25447494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-line-specific high background in the Proteasome-Glo assay of proteasome trypsin-like activity.
    Wilkins OM; Downey SL; Weyburne ES; Williams DA; Mirabella AC; Overkleeft HS; Kisselev AF
    Anal Biochem; 2014 Apr; 451():1-3. PubMed ID: 24486333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells.
    Xu B; Monsarrat B; Gairin JE; Girbal-Neuhauser E
    Fundam Clin Pharmacol; 2004 Apr; 18(2):171-80. PubMed ID: 15066131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of the eukaryotic 20S proteasome.
    Wilk S; Chen WE
    Curr Protoc Protein Sci; 2001 Nov; Chapter 21():Unit 21.6. PubMed ID: 18429167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 26S and PA28-20S Proteasome Activity in Cytosolic Extracts from Embryonic Stem Cells.
    Hernebring M
    Methods Mol Biol; 2016; 1341():359-67. PubMed ID: 25762294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities.
    Kloss A; Henklein P; Siele D; Schmolke M; Apcher S; Kuehn L; Sheppard PW; Dahlmann B
    Eur J Pharm Biopharm; 2009 May; 72(1):219-25. PubMed ID: 19027853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Substrates and Activity-Based Probes for Imaging of the Human Constitutive 20S Proteasome in Cells and Blood Samples.
    Rut W; Poręba M; Kasperkiewicz P; Snipas SJ; Drąg M
    J Med Chem; 2018 Jun; 61(12):5222-5234. PubMed ID: 29806773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of in vitro measurement of proteasome activity in mammalian cells using fluorogenic substrates.
    Georgila K; Voutetakis K; Delitsikou V; Chondrogianni N; Gonos ES
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S31. PubMed ID: 26461338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and processing of misfolded proteins by PA700, the 19S regulatory complex of the 26S proteasome.
    Liu CW; Strickland E; Demartino GN; Thomas PJ
    Methods Mol Biol; 2005; 301():71-81. PubMed ID: 15917627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new fluorogenic peptide determines proteasome activity in single cells.
    Urru SA; Veglianese P; De Luigi A; Fumagalli E; Erba E; Gonella Diaza R; Carrà A; Davoli E; Borsello T; Forloni G; Pengo N; Monzani E; Cascio P; Cenci S; Sitia R; Salmona M
    J Med Chem; 2010 Oct; 53(20):7452-60. PubMed ID: 20883027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human 20S proteasome activity towards fluorogenic peptides of various chain lengths.
    Rut W; Drag M
    Biol Chem; 2016 Sep; 397(9):921-6. PubMed ID: 27176742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoaffinity purification of the functional 20S proteasome from human cells via transient overexpression of specific proteasome subunits.
    Livinskaya VA; Barlev NA; Nikiforov AA
    Protein Expr Purif; 2014 May; 97():37-43. PubMed ID: 24583181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.